Seqens is a global leader in small molecules CDMO, with 60+ years expertise in developing and supplying small molecules APIs, intermediates (RSMs & GMP), and excipients (polymers and lipids).

Our network of cGMP and pre-GMP facilities in Europe and the US and CMC competencies allows our clients full access to integrated services resulting in accelerated time-to-market through a simplified supply chain. Our range of services includes:
- Drug discovery and Preclinical work
- Scale-up
- Custom manufacturing of intermediates (non GMP and GMP) and APIs, including High Potency Compounds and Controlled Substances.
- Solid state design and standalone analytics
- Regulatory support

We also propose innovative technologies allowing to develop more efficient synthesis pathways (Flow chemistry, biocatalysis, asymmetric synthesis) and enhance bioavailability (particle engineering, vectorization).